ROHKEA: Virtual Reality Therapy 12-week Programme for Chronic Pain
Using Interpretative Phenomenological Analysis (IPA): an Exploration of the Therapeutic Benefits of a Virtual Reality Enhanced Cognitive Behavioural Therapy and Movement Therapy 60-day Chronic Pain Management Programme
1 other identifier
interventional
6
1 country
1
Brief Summary
One in four people experience low back pain. 20% of adults suffer with chronic pain, with less than 1% having access to pain management services. Torbay has the highest under 75 years mortality rate in the South West, UK, and chronic pain can account for an increase in mortality by 10 years. Pain Management is seen as a luxury good, and scalable solutions are needed. Using Virtual Reality therapies in the patient's own home, will provide a therapeutic bridge to assist their transition back into richer, and more meaningful lives, despite pain. Virtual reality therapy can offer a 'dress-rehearsal' - to practise Cognitive Behavioural Therapy and movement skills, to support patients to have the courage to leave their homes and step into 'real-life'. It is also of benefit as it fits in with the participants who have other commitments eg work, looking after a relative or other dependents, school run, etc which makes it impossible to access standard treatment as usual. We aim to explore the experiences of 6 patients during their journey through a 12-week pain management programme delivered using Virtual reality and facilitated by a semi-automated mentoring device (SAMI). An Interpretative Phemenological Analysis design will be utilised using semi-structured interviews. The verbatim transcripts of those interviews will be used as the data. Participants will be asked to keep a rolling diary of their experience across the 12-week programme - and to re-read this prior to the interview at the end. Participants will be recruited via the clinical pain rehabilitation team. They will complete a telephone triage and a VR screening tool. Participants will be interviewed 1-2 weeks post completing the programme. The session will be recorded and a transcript generated. Participant characteristics and chronicity of pain will be noted. Themes will be generated from the transcripts, and connections will be sought.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 27, 2024
CompletedStudy Start
First participant enrolled
January 1, 2025
CompletedFirst Posted
Study publicly available on registry
January 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2025
CompletedJanuary 3, 2025
December 1, 2024
6 months
November 27, 2024
December 23, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Participants acceptance and experiences of using a virtual reality therapy 12-week pain management programme
Semi structured interviews to assess user acceptance of the VR equipment (motion sickness, comfort of the headset); the 60 day chronic pain management programme compliance rates (adherence to daily practice, home practice and user engagement with the mobile app).
1-2 weeks post completing the 12 week programme
Participants acceptance and experiences of using a virtual reality therapy 12-week pain management programme
Patient diaries - to assess user acceptance of the VR equipment (motion sickness, comfort of the headset); the 60 day chronic pain management programme compliance rates (adherence to daily practice, home practice and user engagement with the mobile app).
12 weeks
Secondary Outcomes (3)
Brief Pain Inventory (BPI)
completed at assessment, pre and post the 12-week programme
Chronic pain acceptance questionnaire
completed at assessment, pre and post the 12-week programme
Patient Health Questionnaire
completed at assessment, pre and post the 12-week programme
Study Arms (1)
ROHKEA: VR therapy
EXPERIMENTALThis is a pilot/feasibility study using an Interpretative Phenomenological Analysis (IPA) design and semi-structured interviews: to explore the experience of 6 patients with chronic pain going through a VR enhanced CBT and graded exposure 12-week chronic pain management programme.
Interventions
Using Interpretative Phenomenological Analysis (IPA): an exploration of the therapeutic benefits of a Virtual Reality enhanced Cognitive Behavioural Therapy (CBT) and movement (graded exposure) therapy 60-day chronic pain management programme (CPMP). Using the ROHKAE device and undertaking semi structures interviews, pain questionnaires and patient diaries to measure patient experience and pain management
Eligibility Criteria
You may qualify if:
- Adults aged 18-99 years old
- Willing and able to give informed consent
- Experience chronic pain (minimum pain chronicity 3 months)
- Able to use Virtual Reality equipment and satisfy the VR screening form stipulations
- Have access to a smart phone (as need to use the mobile APP) and wifi
- Willing to commit to up to 30minutes home practice a day
- Willing to learn new skills and adopt a self management approach to manage their pain
You may not qualify if:
- Anyone aged less than 18years or over 99 years old
- Unwilling and unable to give informed consent
- Pain less than 3 months
- Unable to use Virtual Reality equipment and do not satisfy the VR screening form stipulations
- Do not have access to a smart phone or wifi
- Are unwilling to commit to up to 30 minutes home practice each day
- Unwilling to learn new skills and adopt a self management approach to manage their pain
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Torbay and South Devon NHS Foundation Trustlead
- Torbay Hospitalcollaborator
Study Sites (1)
Torbay Hospital
Torquay, Devon, TQ2 7AA, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Phillipa Newton Cross
Torbay and South Devon NHS FT
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 27, 2024
First Posted
January 3, 2025
Study Start
January 1, 2025
Primary Completion
July 1, 2025
Study Completion
July 1, 2025
Last Updated
January 3, 2025
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share
individual data will not be shared. Study anonymised data will be shared in results